Chen Ying, Qin Hai, Zheng Lufeng
School of Life Science and Technology, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing, China.
Department of Clinical Laboratory, Guizhou Provincial Orthopedic Hospital, Guiyang, China.
Front Oncol. 2022 Aug 18;12:974523. doi: 10.3389/fonc.2022.974523. eCollection 2022.
Breast cancer is the most common malignancy in women and has a high incidence rate and mortality. Abnormal regulation of gene expression plays an important role in breast cancer occurrence and development. RNA-binding proteins (RBPs) are one kind of the key regulators for gene expression. By interacting with RNA, RBPs are widely involved in RNA cutting, transport, editing, intracellular localization, and translation regulation. RBPs are important during breast cancer occurrence and progression by engaging in many aspects, like proliferation, migration, invasion, and stemness. Therefore, comprehensively understanding the role of RBPs in breast cancer progression can facilitate early diagnosis, timely treatment, and long-term survival and quality of life of breast cancer patients.
乳腺癌是女性中最常见的恶性肿瘤,发病率和死亡率都很高。基因表达的异常调控在乳腺癌的发生和发展中起着重要作用。RNA结合蛋白(RBPs)是基因表达的关键调节因子之一。通过与RNA相互作用,RBPs广泛参与RNA的切割、转运、编辑、细胞内定位和翻译调控。RBPs通过参与增殖、迁移、侵袭和干性等多个方面,在乳腺癌的发生和进展过程中发挥重要作用。因此,全面了解RBPs在乳腺癌进展中的作用有助于乳腺癌患者的早期诊断、及时治疗以及长期生存和生活质量的提高。